Cargando…

Effective drug combinations in breast, colon and pancreatic cancer cells

Combinations of anti-cancer drugs can overcome resistance and provide new treatments(1,2). The number of possible drug combinations vastly exceeds what could be tested clinically. Efforts to systematically identify active combinations and the tissues and molecular contexts in which they are most eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaaks, Patricia, Coker, Elizabeth A., Vis, Daniel J., Edwards, Olivia, Carpenter, Emma F., Leto, Simonetta M., Dwane, Lisa, Sassi, Francesco, Lightfoot, Howard, Barthorpe, Syd, van der Meer, Dieudonne, Yang, Wanjuan, Beck, Alexandra, Mironenko, Tatiana, Hall, Caitlin, Hall, James, Mali, Iman, Richardson, Laura, Tolley, Charlotte, Morris, James, Thomas, Frances, Lleshi, Ermira, Aben, Nanne, Benes, Cyril H., Bertotti, Andrea, Trusolino, Livio, Wessels, Lodewyk, Garnett, Mathew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891012/ https://www.ncbi.nlm.nih.gov/pubmed/35197630 http://dx.doi.org/10.1038/s41586-022-04437-2

Ejemplares similares

Cell Model Passports—a hub for clinical, genetic and functional datasets of preclinical cancer models
por: van der Meer, Dieudonne, et al.
Publicado: (2019)

Drug mechanism‐of‐action discovery through the integration of pharmacological and CRISPR screens
por: Gonçalves, Emanuel, et al.
Publicado: (2020)

Project Score database: a resource for investigating cancer cell dependencies and prioritizing therapeutic targets
por: Dwane, Lisa, et al.
Publicado: (2020)

Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing’s Sarcoma
por: Gill, Sonja J., et al.
Publicado: (2015)

Integrated cross-study datasets of genetic dependencies in cancer
por: Pacini, Clare, et al.
Publicado: (2021)

A Landscape of Pharmacogenomic Interactions in Cancer
por: Iorio, Francesco, et al.
Publicado: (2016)

Discovery of molecular determinants of response to targeted therapies in colorectal cancer using patient-derived xenografts (‘xenopatients’)
por: Sassi, Francesco, et al.
Publicado: (2013)

High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancer
por: Williams, Steven P., et al.
Publicado: (2017)

Corrigendum: High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancer
por: Williams, Steven P., et al.
Publicado: (2018)

Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer
por: Leto, Simonetta M., et al.
Publicado: (2023)

A suspension technique for efficient large-scale cancer organoid culturing and perturbation screens
por: Price, Stacey, et al.
Publicado: (2022)

Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies
por: Leto, Simonetta M., et al.
Publicado: (2014)

β4 integrin activates a Shp2–Src signaling pathway that sustains HGF-induced anchorage-independent growth
por: Bertotti, Andrea, et al.
Publicado: (2006)

Tankyrase inhibition impairs directional migration and invasion of lung cancer cells by affecting microtubule dynamics and polarity signals
por: Lupo, Barbara, et al.
Publicado: (2016)

A diphtheria toxin resistance marker for in vitro and in vivo selection of stably transduced human cells
por: Picco, Gabriele, et al.
Publicado: (2015)

EGAsubmitter: A software to automate submission of nucleic acid sequencing data to the European Genome-phenome Archive
por: Viviani, Marco, et al.
Publicado: (2023)

Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer
por: Rizzo, Giulia, et al.
Publicado: (2021)

Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models
por: Peraldo-Neia, Caterina, et al.
Publicado: (2014)

Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT)
por: Falcinelli, Marta, et al.
Publicado: (2023)

Pan-cancer proteomic map of 949 human cell lines
por: Gonçalves, Emanuel, et al.
Publicado: (2022)

Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
por: Yang, Wanjuan, et al.
Publicado: (2013)

CONNECTOR, fitting and clustering of longitudinal data to reveal a new risk stratification system
por: Pernice, Simone, et al.
Publicado: (2023)

Stratification and prediction of drug synergy based on target functional similarity
por: Yang, Mi, et al.
Publicado: (2020)

iTOP: inferring the topology of omics data
por: Aben, Nanne, et al.
Publicado: (2018)

MicroRNA 483‐3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axis
por: Candiello, Ermes, et al.
Publicado: (2023)

Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells
por: Kolluri, Krishna Kalyan, et al.
Publicado: (2018)

Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
por: Grinkevitch, Vera, et al.
Publicado: (2022)

Patient‐specific logic models of signaling pathways from screenings on cancer biopsies to prioritize personalized combination therapies
por: Eduati, Federica, et al.
Publicado: (2020)

Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition
por: Corso, Simona, et al.
Publicado: (2010)

Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity
por: Leuci, V., et al.
Publicado: (2016)

Experience-Dependent Plasticity and Modulation of Growth Regulatory Molecules at Central Synapses
por: Foscarin, Simona, et al.
Publicado: (2011)

Endogenous polyamine function—the RNA perspective
por: Lightfoot, Helen L., et al.
Publicado: (2014)

Target mRNA inhibition by oligonucleotide drugs in man
por: Lightfoot, Helen L., et al.
Publicado: (2012)

Multi-label transcriptional classification of colorectal cancer reflects tumor cell population heterogeneity
por: Cascianelli, Silvia, et al.
Publicado: (2023)

Genomic data integration by WON-PARAFAC identifies interpretable factors for predicting drug-sensitivity in vivo
por: Kim, Yongsoo, et al.
Publicado: (2019)

AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors
por: Dunn, Shanade, et al.
Publicado: (2022)

Russia’s Cosmonauts: Inside the Yuri Gagarin Training Center
por: Hall, Rex D, et al.
Publicado: (2005)

SLFN11 informs on standard of care and novel treatments in a wide range of cancer models
por: Winkler, Claudia, et al.
Publicado: (2020)

The leadership roadmap: people, lean, and innovation
por: Baumgardner, Dwane, et al.
Publicado: (2019)

Identification of a branchial cleft anomaly via handheld point-of-care ultrasound
por: Brad Hall, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ihk6o75r56jh4918da135p5b5